News
As revenue reporting season hits full stride, firms have made a point of highlighting the successes of their IP teams as they ...
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results